{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:50:17Z","timestamp":1781067017021,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01271-3","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:23:47Z","timestamp":1754414627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Expanding buprenorphine prescribing in primary care: a qualitative study of the experiences of primary care providers and nurse care managers participating in the New York City buprenorphine nurse care manager initiative"],"prefix":"10.1186","volume":"22","author":[{"given":"Elodie C.","family":"Warren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Beharie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Kaplan-Dobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmara","family":"Tesfaye Rogoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Harocopos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"1271_CR1","unstructured":"U.S. Government Accountability Office. Opioid crisis: Status of public health emergency authorities (GAO Publication No. 18-685R). U.S. Government Printing Office. 2018."},{"key":"1271_CR2","unstructured":"Tuazon E, Bauman M, Sun T, Weitz A, DeWalt J, Mantha S, Harocopos A. Unintentional drug poisoning (overdose) deaths in New York City in 2022. Epi Data Brief (137). New York City Department of Health and Mental Hygiene."},{"key":"1271_CR3","unstructured":"Tuazon E, Sun T, Weitz A, Gasdaska B, Clarke-Crichton G, Zaidi I, Fulmer C, McAteer J, Mantha S. Unintentional drug poisoning (overdose) deaths in New York City in 2023. Epi Data Brief (142). New York City Department of Health and Mental Hygiene."},{"key":"1271_CR4","doi-asserted-by":"publisher","first-page":"c5475","DOI":"10.1136\/bmj.c5475","volume":"341","author":"R Cornish","year":"2010","unstructured":"Cornish R, Macleod J, Strang J, Vickerman P, Hickman M. Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK general practice research database. BMJ. 2010;341:c5475.","journal-title":"BMJ"},{"key":"1271_CR5","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.","journal-title":"BMJ"},{"key":"1271_CR6","unstructured":"Substance abuse and mental health services administration. Medications for opioid use disorder: treatment improvement protocol (TIP) series 63. Rockville (MD): SAMHSA. 2021."},{"issue":"6","key":"1271_CR7","doi-asserted-by":"publisher","first-page":"912","DOI":"10.15288\/jsa.2000.61.912","volume":"61","author":"JH Isaacson","year":"2000","unstructured":"Isaacson JH, Fleming M, Kraus M, Kahn R, Mundt M. A national survey of training in substance use disorders in residency programs. J Stud Alcohol. 2000;61(6):912\u20135.","journal-title":"J Stud Alcohol"},{"key":"1271_CR8","unstructured":"National center on addiction and substance abuse at Columbia University. Addiction medicine: Closing the gap between science and practice. Columbia University. 2012."},{"issue":"5","key":"1271_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1176\/appi.ps.202000565","volume":"73","author":"J McNeely","year":"2022","unstructured":"McNeely J, Schatz D, Olfson M, Appleton N, Williams AR. How physician workforce shortages are hampering the response to the opioid crisis. Psychiatr Serv. 2022;73(5):547\u201354.","journal-title":"Psychiatr Serv"},{"issue":"1","key":"1271_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13722-018-0110-8","volume":"13","author":"J McNeely","year":"2018","unstructured":"McNeely J, Kumar PC, Rieckmann T, Sedlander E, Farkas S, Chollak C, et al. Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff. Addict Sci Clin Pract. 2018;13(1):1\u201315.","journal-title":"Addict Sci Clin Pract"},{"key":"1271_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC van Boekel","year":"2013","unstructured":"van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131:23\u201335.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1271_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11606-008-0881-9","volume":"24","author":"DT Barry","year":"2009","unstructured":"Barry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, et al. Integrating buprenorphine treatment into office-based practice: a qualitative study. J Gen Intern Med. 2009;24(2):218\u201325.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"1271_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1370\/afm.1595","volume":"12","author":"E Hutchinson","year":"2014","unstructured":"Hutchinson E, Catlin M, Andrilla CH, Baldwin LM, Rosenblatt RA. Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med. 2014;12(2):128\u201333.","journal-title":"Ann Fam Med"},{"issue":"9","key":"1271_CR14","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s11606-008-0686-x","volume":"23","author":"AY Walley","year":"2008","unstructured":"Walley AY, Alperen JK, Cheng DM, Botticelli M, Castro-Donlan C, Samet JH, et al. Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers. J Gen Intern Med. 2008;23(9):1393\u20138.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"1271_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/1475-6773.13113","volume":"54","author":"AJ Abraham","year":"2019","unstructured":"Abraham AJ, Adams GB, Bradford AC, Bradford WD. County-level access to opioid use disorder medications in medicare part D (2010\u20132015). Health Serv Res. 2019;54(2):390\u20138.","journal-title":"Health Serv Res"},{"key":"1271_CR16","doi-asserted-by":"publisher","first-page":"108710","DOI":"10.1016\/j.drugalcdep.2021.108710","volume":"223","author":"MS Schuler","year":"2021","unstructured":"Schuler MS, Dick AW, Stein BD. Growing racial\/ethnic disparities in buprenorphine distribution in the United States, 2007\u20132017. Drug Alcohol Depend. 2021;223:108710.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"1271_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","volume":"76","author":"PA Lagisetty","year":"2019","unstructured":"Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine treatment divide by race\/ethnicity and payment. JAMA Psychiat. 2019;76(9):979\u201381.","journal-title":"JAMA Psychiat"},{"issue":"3","key":"1271_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","volume":"40","author":"HB Hansen","year":"2013","unstructured":"Hansen HB, Siegel CE, Case BG, Bertollo DN, DiRocco D, Galanter M. Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City. J Behav Health Serv Res. 2013;40(3):367\u201377.","journal-title":"J Behav Health Serv Res"},{"key":"1271_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2016.03.028","volume":"164","author":"H Hansen","year":"2016","unstructured":"Hansen H, Siegel C, Wanderling J, DiRocco D. Buprenorphine and methadone treatment for opioid dependence by income, ethnicity, and race of neighborhoods in New York City. Drug Alcohol Depend. 2016;164:14\u201321.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1271_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2105\/AJPH.2020.306000","volume":"111","author":"M Kaplan-Dobbs","year":"2021","unstructured":"Kaplan-Dobbs M, Kattan JA, Tuazon E, Jimenez C, Saleh S, Kunins HV. Increasing access to buprenorphine in safety-net primary care clinics: the New York City buprenorphine nurse care manager initiative. Am J Public Health. 2021;111(2):215\u20138.","journal-title":"Am J Public Health"},{"key":"1271_CR21","unstructured":"Rogers EM, Singhal A, Quinlan MM. Diffusion of innovations. In: An integrated approach to communication theory and research. Routledge. 2014."},{"issue":"5","key":"1271_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/1049731509335569","volume":"19","author":"JW Dearing","year":"2009","unstructured":"Dearing JW. Applying diffusion of innovation theory to intervention development. Res Soc Work Pract. 2009;19(5):503\u201318.","journal-title":"Res Soc Work Pract"},{"key":"1271_CR23","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2147\/CIA.S64723","volume":"9","author":"V Khanassov","year":"2014","unstructured":"Khanassov V, Vedel I, Pluye P. Case management for dementia in primary health care: a systematic mixed studies review based on the diffusion of innovation model. Clin Interv Aging. 2014;9:915\u201328.","journal-title":"Clin Interv Aging"},{"key":"1271_CR24","doi-asserted-by":"publisher","first-page":"102964","DOI":"10.1016\/j.drugpo.2020.102964","volume":"86","author":"AD Marshall","year":"2020","unstructured":"Marshall AD, Hopwood M, Grebely J, Treloar C. Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: identified challenges for widespread implementation. Int J Drug Policy. 2020;86:102964.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"1271_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jpag.2016.11.005","volume":"30","author":"MK Murphy","year":"2017","unstructured":"Murphy MK, Burke PJ, Haider S. A qualitative application of diffusion of innovations to adolescents\u2019 perceptions of long-acting reversible contraception\u2019s attributes. J Pediatr Adolesc Gynecol. 2017;30(4):484\u201390.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"1271_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/1049732318800289","volume":"29","author":"JM Bowles","year":"2019","unstructured":"Bowles JM, Lankenau SE. I gotta go with modern technology, so I\u2019m gonna give \u2019em the Narcan: the diffusion of innovations and an opioid overdose prevention program. Qual Health Res. 2019;29(3):345\u201356.","journal-title":"Qual Health Res"},{"issue":"2","key":"1271_CR27","first-page":"95","volume":"14","author":"S Elison","year":"2014","unstructured":"Elison S, Ward J, Davies G, Moody M. Implementation of computer-assisted therapy for substance misuse: a qualitative study of breaking free online using Roger\u2019s diffusion of innovation theory. Drugs Alcohol Today. 2014;14(2):95\u2013103.","journal-title":"Drugs Alcohol Today"},{"issue":"3","key":"1271_CR28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jsat.2013.09.002","volume":"46","author":"CA Green","year":"2014","unstructured":"Green CA, McCarty D, Mertens J, Lynch FL, Hilde A, Firemark A, et al. A qualitative study of the adoption of buprenorphine for opioid addiction treatment. J Subst Abuse Treat. 2014;46(3):390\u2013401.","journal-title":"J Subst Abuse Treat"},{"key":"1271_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jsat.2015.06.010","volume":"60","author":"CT LaBelle","year":"2016","unstructured":"LaBelle CT, Han SC, Bergeron A, Samet JH. Office-based opioid treatment with buprenorphine (OBOT-B): statewide implementation of the Massachusetts collaborative care model in community health centers. J Subst Abuse Treat. 2016;60:6\u201313.","journal-title":"J Subst Abuse Treat"},{"key":"1271_CR30","doi-asserted-by":"publisher","first-page":"108633","DOI":"10.1016\/j.jsat.2021.108633","volume":"132","author":"N Beharie","year":"2022","unstructured":"Beharie N, Kaplan-Dobbs M, Urmanche A, Paone D, Harocopos A. \u201cI didn\u2019t feel like a number\u201d: the impact of nurse care managers on the provision of buprenorphine treatment in primary care settings. J Subst Abuse Treat. 2022;132:108633.","journal-title":"J Subst Abuse Treat"},{"key":"1271_CR31","doi-asserted-by":"crossref","unstructured":"Khalid L, Cunningham CO, Deng Y, Masyukova M, Bumol J, Valle A, et al. Cascade of care for office-based buprenorphine treatment in Bronx community clinics. J Subst Abuse Treat. 2022; 108778.","DOI":"10.1016\/j.jsat.2022.108778"},{"issue":"5","key":"1271_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","volume":"171","author":"DP Alford","year":"2011","unstructured":"Alford DP, LaBelle CT, Kretsch N, Bergeron A, Winter M, Botticelli M, et al. Five year experience with collaborative care of opioid addicted patients using Buprenorphine in primary care. Arch Intern Med. 2011;171(5):425.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1271_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1370\/afm.2587","volume":"18","author":"JE Fried","year":"2020","unstructured":"Fried JE, Basu S, Phillips RS, Landon BE. Financing buprenorphine treatment in primary care: a microsimulation model. Annals Family Med. 2020;18(6):535\u201344.","journal-title":"Annals Family Med"},{"issue":"2","key":"1271_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"1271_CR35","unstructured":"Guest G, MacQueen KM, Namey EE. Integrating qualitative and quantitative data. In: Applied Thematic Analysis. Sage. 2014."},{"key":"1271_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13104-016-1954-1","volume":"9","author":"D Grossoehme","year":"2016","unstructured":"Grossoehme D, Lipstein E. Analyzing longitudinal qualitative data: the application of trajectory and recurrent cross-sectional approaches. BMC Res Notes. 2016;9:136.","journal-title":"BMC Res Notes"},{"issue":"4","key":"1271_CR37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00006223-200307000-00008","volume":"28","author":"ZR Wolf","year":"2003","unstructured":"Wolf ZR. Exploring the audit trail for qualitative investigations. Nurse Educ. 2003;28(4):175\u20138.","journal-title":"Nurse Educ"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01271-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01271-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01271-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:59:40Z","timestamp":1757357980000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01271-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1271"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01271-3","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the NYC Health Department\u2019s Institutional Review Board. All participants provided written informed consent before participating in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}